Mohammed Al Jumah, Suleiman Kojan, Raed Alroughani, Edward Cupler, Saeed Bohlega, Abdulkader Daif, Mousa Al Mujalli, Talal Al Harbi, Mohamed El Tamawy, Samia Ashour, Chokri Mhiri, Riadh Gouider, Ayah Jawhary, Ahmed El Boghdady, Mohamed Hussein
Few studies examine health-related quality of life (HRQoL) in Arabic-speaking multiple sclerosis (MS) patients. However, HRQoL tools such as the Short Form-36 QoL instrument (SF-36) and the Multiple Sclerosis International QoL (MusiQoL) questionnaire have been validated in other languages. The primary objective of this study was to prospectively assess HRQoL using the MusiQoL questionnaire among Arabic-speaking MS patients treated with subcutaneous interferon (sc IFN β -1a) over 12 months, as part of a prospective, multinational, multicenter cohort study...
2021: Multiple Sclerosis International